VaxInnate - Media Center

Technology (PDF)

Corporate (PDF)

Influenza (PDF)

APC Presentation (PPT)

VAXINNATE in NEWS


12/1-12/2/2010 London, EUROPE	Vaccines Europe 2010 Join us for 2010's Vaccines Europe, set to be Informa's best yet! Read more



11/9-11/11/2010 Washington, DC	Influenza Congress USA – Washington DC Commercial development and investment opportunities in influenza vaccines and antivirals Read more



11/2-11/4/2010 Boston, USA	Top 10 Most interesting Infectious Diseases Projects to Watch; Dr. Becker Presented – Received award Read more



9/3-9/7/2010 Hong Kong SAR	Options for the Control of Influenza VII; More than 1,400 Researchers from all corners of the globe convened in Hong Kong, SAR, China for Options for the Control of Influenza VII. Read more
VaxInnate in News

12/19/2011	VaxInnate Licenses Recombinant Flu Vaccines To CJ CheilJedang Corporation of South Korea.


04/21/2011	U.S. Congressman Rush Holt Visits VaxInnate Lauds Government Funding for Development of Modern Flu Vaccines.
03/01/2011	VaxInnate Awarded Contract by the U.S. Government Potential value of contract as high as $196 million
02/28/2011	HHS awards contracts to develop new flu vaccine technology- VaxInnate VaxInnate received a HHS contract for the development

11/01/2010	VaxInnate's Novel Recombinant Flu Vaccine Named a Top 110 Biopharma Project to watch in 2011 Vax125 was selected by an expert panel

04/27/2010	VaxInnate's VAX125 Seasonal Flu Vaccine Shown Safe and Highly Immunogenic in Phase II Study of Elderly Subjects; We should be able to provide a much-needed new option for protecting the elderly against seasonal flu

03/18/2010	Hofstaetter named President and CEO; Shaw names CSO and Chairman; We're pleased that Thomas Hofstaetter has agreed to lead VaxInnate as we begin a new chapter



01/12/2010	VaxInnate Licenses Recombinant H1N1 Pandemic Swine Flu Vaccine to Biological E.; Vaccine Could Become Available for Use in India This Year








Read more